1. Home
  2. ENSC vs AREB Comparison

ENSC vs AREB Comparison

Compare ENSC & AREB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENSC
  • AREB
  • Stock Information
  • Founded
  • ENSC 2003
  • AREB 2014
  • Country
  • ENSC United States
  • AREB United States
  • Employees
  • ENSC N/A
  • AREB N/A
  • Industry
  • ENSC Biotechnology: Pharmaceutical Preparations
  • AREB Plastic Products
  • Sector
  • ENSC Health Care
  • AREB Industrials
  • Exchange
  • ENSC Nasdaq
  • AREB Nasdaq
  • Market Cap
  • ENSC 6.4M
  • AREB 6.7M
  • IPO Year
  • ENSC N/A
  • AREB N/A
  • Fundamental
  • Price
  • ENSC $2.46
  • AREB $7.03
  • Analyst Decision
  • ENSC
  • AREB
  • Analyst Count
  • ENSC 0
  • AREB 0
  • Target Price
  • ENSC N/A
  • AREB N/A
  • AVG Volume (30 Days)
  • ENSC 149.6K
  • AREB 671.2K
  • Earning Date
  • ENSC 11-11-2025
  • AREB 11-11-2025
  • Dividend Yield
  • ENSC N/A
  • AREB N/A
  • EPS Growth
  • ENSC N/A
  • AREB N/A
  • EPS
  • ENSC N/A
  • AREB N/A
  • Revenue
  • ENSC $7,413,722.00
  • AREB $9,474,958.00
  • Revenue This Year
  • ENSC N/A
  • AREB N/A
  • Revenue Next Year
  • ENSC $1,354.55
  • AREB N/A
  • P/E Ratio
  • ENSC N/A
  • AREB N/A
  • Revenue Growth
  • ENSC 415.58
  • AREB N/A
  • 52 Week Low
  • ENSC $1.62
  • AREB $5.55
  • 52 Week High
  • ENSC $14.67
  • AREB $1,947.50
  • Technical
  • Relative Strength Index (RSI)
  • ENSC 66.12
  • AREB 49.18
  • Support Level
  • ENSC $2.35
  • AREB $5.56
  • Resistance Level
  • ENSC $2.64
  • AREB $28.00
  • Average True Range (ATR)
  • ENSC 0.16
  • AREB 2.19
  • MACD
  • ENSC 0.02
  • AREB -0.24
  • Stochastic Oscillator
  • ENSC 76.79
  • AREB 19.07

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About AREB American Rebel Holdings Inc.

American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.

Share on Social Networks: